Clinical Trial: Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

Sponsor and Collaborators
University of Pennsylvania
Celgene Corporation

Contact
Contact: Stephen J Schuster, MD
215-614-1846
schustes@mail.med.upenn.edu


Continue Reading

Principal Investigator
Stephen J Schuster, MD University of Pennsylvania

ClinicalTrials.gov Identifier

NCT00783367